Tien Liang BioTech Co., Ltd. (TPEX:4127)
Taiwan · Delayed Price · Currency is TWD 62.00
0.00 (0.00%)
Sep 8, 2026, 1:30 PM CST
Tien Liang BioTech Market Cap
Tien Liang BioTech has a market cap or net worth of 2.84 billion as of September 8, 2026. Its market cap has increased by 82.35% in one year.
Market Cap
2.84B
Enterprise Value
3.24B
Revenue
650.87M
Ranking
n/a
PE Ratio
41.06
Stock Price
62.00
ChartMarket Cap Chart
Since July 19, 2005, Tien Liang BioTech's market cap has increased from 767.70M to 2.84B, an increase of 269.56%. That is a compound annual growth rate of 6.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 2.84B | 100.00% |
| Dec 31, 2025 | 1.42B | -25.30% |
| Dec 31, 2024 | 1.90B | 186.21% |
| Dec 29, 2023 | 663.52M | -6.15% |
| Dec 30, 2022 | 706.99M | 4.39% |
| Dec 30, 2021 | 677.25M | 32.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Panion & Bf Biotech | 4.84B |
| LIWANLI Innovation | 4.66B |
| Yoda Pharmaceuticals | 4.61B |
| Orient EuroPharma | 3.99B |
| Easywell Biomedicals | 3.73B |
| Maywufa Company | 2.78B |
| Allied Biotech | 2.67B |
| PhytoHealth | 2.26B |